Literature DB >> 10023952

Cirrhosis with steatohepatitis after adjuvant tamoxifen.

K A Oien, D Moffat, G W Curry, J Dickson, T Habeshaw, P R Mills, R N MacSween.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10023952     DOI： 10.1016/S0140-6736(05)74872-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  25 in total

1.  Cirrhosis with steatohepatitis following longterm stilboestrol treatment.

Authors:  L Cooper; M Palmer; K Oien
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

2.  Diffuse desmoplastic metastatic breast cancer simulating cirrhosis with severe portal hypertension: a case of "pseudocirrhosis".

Authors:  David A Sass; Kenneth Clark; Dana Grzybicki; Mordechai Rabinovitz; Thomas A Shaw-Stiffel
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.199

Review 3.  Drug-induced Liver Injury: The Hepatic Pathologist's Approach.

Authors:  David E Kleiner
Journal:  Gastroenterol Clin North Am       Date:  2017-06       Impact factor: 3.806

Review 4.  Role of Estrogens in the Regulation of Liver Lipid Metabolism.

Authors:  Brian T Palmisano; Lin Zhu; John M Stafford
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

5.  Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women.

Authors:  Masahide Hamaguchi; Takao Kojima; Akihiro Ohbora; Noriyuki Takeda; Michiaki Fukui; Takahiro Kato
Journal:  World J Gastroenterol       Date:  2012-01-21       Impact factor: 5.742

6.  Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice.

Authors:  Y Nemoto; K Toda; M Ono; K Fujikawa-Adachi; T Saibara; S Onishi; H Enzan; T Okada; Y Shizuta
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

7.  Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial.

Authors:  Savino Bruno; Patrick Maisonneuve; Paola Castellana; Nicole Rotmensz; Sonia Rossi; Marco Maggioni; Marcello Persico; Alberto Colombo; Franco Monasterolo; Donata Casadei-Giunchi; Franco Desiderio; Tommaso Stroffolini; Virgilio Sacchini; Andrea Decensi; Umberto Veronesi
Journal:  BMJ       Date:  2005-03-03

8.  Pitavastatin ameliorates severe hepatic steatosis in aromatase-deficient (Ar-/-) mice.

Authors:  Tetsu Egawa; Katsumi Toda; Yoshihisa Nemoto; Masafumi Ono; Naoaki Akisaw; Toshiji Saibara; Yoshihiro Hayashi; Makoto Hiroi; Hideaki Enzan; Saburo Onishi
Journal:  Lipids       Date:  2003-05       Impact factor: 1.880

9.  A case-control study of non-alcoholic fatty liver disease in breast cancer.

Authors:  Ahmet Bilici; Mustafa Ozguroglu; Ismail Mihmanli; Hande Turna; Ibrahim Adaletli
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

Review 10.  Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection.

Authors:  Ichiro Shimizu; Nao Kohno; Katsuyoshi Tamaki; Masayuki Shono; Hui-Wei Huang; Jiang-Hong He; Deng-Fu Yao
Journal:  World J Gastroenterol       Date:  2007-08-28       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.